Impact of Achieving Minimal Disease Activity on Patient-Reported Outcome Measures and Disease Activity Among Patients with Psoriatic Arthritis Treated with Biologic and Targeted Synthetic DMARDs

被引：0
|
作者：
Ogdie, Alexis [1 ]
McLean, Robert [2 ]
Marchese, Maya [2 ]
Blachley, Taylor [2 ]
Anatale-Tardiff, Laura [3 ]
Saffore, Christopher [4 ]
Douglas, Kevin [5 ]
Quach, Danny [5 ]
Mease, Philip [6 ,7 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] CorEvitas LLC, Waltham, MA USA
[3] CorEvitas, Waltham, MA USA
[4] AbbVie, N Chicago, IL 60064 USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Swedish Med Ctr Providence St Joseph Hlth, Seattle, WA USA
[7] Univ Washington, Seattle, WA 98195 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1344
引用
收藏
页码：2798 / 2801
页数：4
相关论文
共 50 条
  • [1] Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs
    Mease, Philip
    McLean, Robert
    Blachley, Taylor
    Marchese, Maya
    Anatale-Tardiff, Laura
    Ore, Christopher Saff
    Quach, Danny
    Biljan, Ana
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1928 - 1931
  • [2] Patient-reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review
    Pickles, Tim
    Choy, Ernest
    Horton, Mike
    Christensen, Karl Bang
    Phillips, Rhiannon
    Gillespie, David
    Macefield, Rhiannon
    Aiyegbusi, Olalekan Lee
    Beecher, Claire
    QUALITY OF LIFE RESEARCH, 2021, 30 (SUPPL 1) : S149 - S149
  • [3] Patient-reported outcome measures for rheumatoid arthritis disease activity: a systematic review
    Pickles, Tim
    Ijaz, Tanzeel
    Horton, Mike
    Christensen, Karl Bang
    Phillips, Rhiannon
    Gillespie, David
    Choy, Ernest
    QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S158 - S158
  • [4] Responsiveness and Minimal Clinically Important Difference in Patient-Reported Outcome Measures Among Patients with Psoriatic Arthritis
    Karmacharya, Paras
    Stull, Courtney
    Stephens-Shields, Alisa
    Husni, M. Elaine
    Scher, Jose
    Craig, Ethan
    Fitzsimmons, Robert
    Reddy, Soumya
    Magrey, Marina
    Ogdie, Alexis
    Walsh, Jessica
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2034 - 2037
  • [5] ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Mease, P. J.
    Gottlieb, A. B.
    Ogdie, A.
    Assudani, D.
    Coarse, J.
    Ink, B.
    Coates, L. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1683 - 1683
  • [6] Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis
    Looijen, Agnes E. M.
    Snoeck Henkemans, Selinde V. J.
    van der Helm-van Mil, Annette H. M.
    Welsing, Paco M. J.
    Koc, Gonul Hazal
    Luime, Jolanda J.
    Kok, Marc R.
    Tchetverikov, Ilja
    Korswagen, Lindy-Anne
    Baudoin, Paul
    Vis, Marijn
    de Jong, Pascal H. P.
    RMD OPEN, 2024, 10 (04):
  • [7] Unmet Criteria for Achieving Minimal and Very Low Disease Activity Among Patients with Psoriatic Arthritis Initiating Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in the CorEvitas PsA/SpA Registry
    Ogdie, Alexis
    Song, Chao
    Middaugh, Nicole
    Marchese, Maya
    Eliot, Melissa
    Low, Robert
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1177 - 1180
  • [8] Correlation of patient-reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis
    Ward, Louise
    Oliffe, Michael
    Kane, Barry
    Chessman, Diana
    Meaney, Donna
    Briggs, Fiona
    Gibson, Kathryn
    Barnsley, Les
    Sumpton, Daniel
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (05) : 584 - 591
  • [9] Impact of risankizumab on achieving minimal clinically important differences in patient-reported disease activity, fatigue, and pain among patients with active psoriatic arthritis: Analysis of 2 phase 3 clinical trials
    Kristensen, Lars Erik
    Soliman, Ahmed
    Papp, Kim
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB68 - AB68
  • [10] Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
    Hendrikx, Jos
    de Jonge, Marieke J.
    Fransen, Jaap
    Kievit, Wietske
    van Riel, Piet L. C. M.
    RMD OPEN, 2016, 2 (02):
12345